HIGHLIGHTS
- who: Ava Cote and collaborators from the Department of Pathology and Laboratory Medicine, Redox Biology Program, University of Vermont Larner College of Medicine, Burlington, VT, USA have published the research work: Reactive oxygen species in the progression and treatment of malignant mesothelioma, in the Journal: (JOURNAL)
- what: ROS have a complicated role in the development of MM and many other cancers.
- how: This review discusses ROS sources and signaling mitochondrial structure and function and targeting mitochondria ROS as a therapeutic approach for the treatment of MM.
- future: Although more research is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.